Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 127 citing Kim: Development and characterization of a glucagon-like peptide 1-albumin conjugate. (0.11 sec) 

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl …


DJ Drucker, MA Nauck - The Lancet, 2006 - Elsevier
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that stimulates insulin and
suppresses glucagon secretion, inhibits gastric emptying, and reduces appetite and food
intake. Therapeutic approaches for enhancing incretin action include ...
Cited by 416 - Related articles - All 10 versions

Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the …

- endojournals.org
PL Brubaker, DJ Drucker - Endocrinology, 2004 - Endocrine Soc
Gut peptides exert diverse effects regulating satiety, gastrointestinal motility and acid
secretion, epithelial integrity, and both nutrient absorption and disposal. These actions are initiated
by activation of specific G protein-coupled receptors and may be mediated by direct or ...
Cited by 217 - Related articles - BL Direct - All 7 versions

Therapeutic strategies based on glucagon-like peptide 1

- diabetesjournals.org
CF Deacon - Diabetes, 2004 - Am Diabetes Assoc
Glucagon-like peptide (GLP)-1 is an incretin hormone with potent glucose-dependent insulinotropic
and glucagonostatic actions, trophic effects on the pancreatic β-cells, and inhibitory effects on
gastrointestinal secretion and motility, which combine to lower plasma glucose and ...
Cited by 155 - Related articles - BL Direct - All 5 versions

Double incretin receptor knockout (DIRKO) mice reveal an essential role for the …

- diabetesjournals.org
T Hansotia, LL Baggio, D Delmeire, SA Hinke, Y … - Diabetes, 2004 - Am Diabetes Assoc
Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are
gut-derived incretins that potentiate glucose clearance following nutrient ingestion. Elimination
of incretin receptor action in GIPR −/− or GLP-1R −/− mice produces only modest ...
Cited by 110 - Related articles - BL Direct - All 13 versions

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes


MA Nauck, JJ Meier - Regulatory peptides, 2005 - Elsevier
Glucagon-like peptide 1 (GLP-1) was discovered as an insulinotropic gut hormone, suggesting
a physiological role as an incretin hormone, ie, being responsible, in part, for the higher insulin
secretory response after oral as compared to intravenous glucose administration. This ...
Cited by 107 - Related articles - All 6 versions

Glucagon-Like Peptide-1 and the Islet {beta}-Cell: Augmentation of Cell …

- endojournals.org
DJ Drucker - Endocrinology, 2003 - Endocrine Soc
Studies of the natural history of type 2 diabetes inform us that a progressive decline in ß-cell
function is common in diabetic patients independent of the method of treatment (2). Hence, new
approaches are clearly needed that not only control metabolic abnormalities such as ...
Cited by 102 - Related articles - BL Direct - All 4 versions

A recombinant human glucagon-like peptide (GLP)-1–albumin protein (albugon) …

- diabetesjournals.org
LL Baggio, Q Huang, TJ Brown, DJ Drucker - Diabetes, 2004 - Am Diabetes Assoc
Peptide hormones exert unique actions via specific G protein–coupled receptors; however, the
therapeutic potential of regulatory peptides is frequently compromised by rapid enzymatic inactivation
and clearance from the circulation. In contrast, recombinant or covalent coupling of ...
Cited by 96 - Related articles - BL Direct - All 11 versions

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric …


JJ Meier, MA Nauck, D Kranz, JJ Holst, CF Deacon, D … - Diabetes, 2004 - Am Diabetes Assoc
Glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) are important factors
in the pathogenesis of type 2 diabetes and have a promising therapeutic potential. Alterations
of their secretion, in vivo degradation, and elimination in patients with chronic renal ...
Cited by 89 - Related articles - BL Direct - All 4 versions

Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema …

- cjb.net
H Yamamoto, T Kishi, CE Lee, BJ Choi, H Fang, … - Journal of …, 2003 - neuro.cjb.net
Glucagon-like peptide-1 (GLP-1) released from the gut is an incretin that stimulates insulin
secretion. GLP-1 is also a brain neuropeptide that has diverse central actions, including inhibition
of food and water intake, gastric emptying, and stimulation of neuroendocrine responses ...
Cited by 84 - Related articles - BL Direct - All 9 versions

The role of gut hormones in glucose homeostasis

- nih.gov
DJ Drucker - Journal of Clinical Investigation, 2007 - Am Soc Clin Investig
The gastrointestinal tract has a crucial role in the control of energy homeostasis through its role
in the digestion, absorption, and assimilation of ingested nutrients. Furthermore, signals from
the gastrointestinal tract are important regulators of gut motility and satiety, both of which ...
Cited by 87 - Related articles - BL Direct - All 11 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google